Brussels, 25/09/2009 (Agence Europe) - In a press release published on Friday 25 September, the European Medicines Agency (EMEA) says it has made a recommendation to the European Commission that vaccines, Focetria (Novartis) and Pandemrix (GlaxoSmithKline), against flu virus A(H1N1) be granted marketing authorisation. The Agency is currently recommending two vaccinations, three weeks apart, for adults, including expectant mothers, and children from the age of six months. The Agency committee...